{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:36:12Z","timestamp":1778193372916,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4246,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1053\/seiz.2001.0555","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T10:55:08Z","timestamp":1032432908000},"page":"596-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Anticonvulsants-induced chorea: a role for pharmacodynamic drug interaction?"],"prefix":"10.1053","volume":"10","author":[{"given":"Megdad","family":"Zaatreh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Tennison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O'Neill","family":"D'Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L","family":"Beach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/seiz.2001.0555_RF1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.870080104","article-title":"Phenytoin and dyskinesia: a report of two cases and review of the literature","volume":"8","author":"Harrison","year":"1993","journal-title":"Movement Disorder"},{"key":"10.1053\/seiz.2001.0555_RF2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3949\/ccjm.57.4.367","article-title":"Carbamazepine-induced dyskinesia and ophthalmoplegia","volume":"57","author":"Schwartzman","year":"1990","journal-title":"Cleveland Clinic Journal of Medicine"},{"key":"10.1053\/seiz.2001.0555_RF3","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1528-1157.1996.tb00537.x","article-title":"Movement disorders associated with the use of gabapentin","volume":"37","author":"Reeves","year":"1996","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0555_RF4","first-page":"910","article-title":"Choreoathetosis as a side effect of gabapentin therapy in severely neurologically impaired patients","volume":"54","author":"Chudnow","year":"1997","journal-title":"Archives of Neurology"},{"key":"10.1053\/seiz.2001.0555_RF5","first-page":"851","article-title":"Choreoathetotic movements: a possible side effect of gabapentin","volume":"64","author":"Buetefish","year":"1996","journal-title":"Neurology"},{"key":"10.1053\/seiz.2001.0555_RF6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/WNL.45.1.185","article-title":"Involuntary movement disorders associated with felbamate","volume":"45","author":"Keerick","year":"1995","journal-title":"Neurology"},{"key":"10.1053\/seiz.2001.0555_RF7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archneur.1994.00540190086020","article-title":"Choreiform movements associated with the use of valproate","volume":"51","author":"Lancman","year":"1994","journal-title":"Archives of Neurology"},{"key":"10.1053\/seiz.2001.0555_RF8","first-page":"299","article-title":"Anticonvulsant drug intolerance","volume":"12","author":"Peters","year":"1962","journal-title":"Neurology"},{"key":"10.1053\/seiz.2001.0555_RF9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1528-1157.1977.tb04984.x","article-title":"Phenytoin-induced hyperkinesia","volume":"18","author":"Luhdorf","year":"1977","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0555_RF10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3476(76)80956-0","article-title":"Phenytoin-induced choreoathetosis","volume":"89","author":"Chalhub","year":"1976","journal-title":"Journal of Pediatrics"},{"key":"10.1053\/seiz.2001.0555_RF11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.870110128","article-title":"Phenytoin-induced focal chorea","volume":"11","author":"Shulman","year":"1976","journal-title":"Movement Disorder"},{"key":"10.1053\/seiz.2001.0555_RF12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0022-3476(87)80570-X","article-title":"Transient chorea induced by Phenytoin","volume":"110","author":"Filloux","year":"1987","journal-title":"Journal of Pediatrics"},{"key":"10.1053\/seiz.2001.0555_RF13","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/088307389601100617","article-title":"Phenytoin-related chorea in children with deep hemispheric vascular malformations","volume":"11","author":"Koukkari","year":"1996","journal-title":"Journal of Child Neurology"},{"key":"10.1053\/seiz.2001.0555_RF14","first-page":"112","article-title":"Movement disorder associated with lamotrigine treatment in children and adolescents (abstract)","volume":"37","author":"Frost","year":"1996","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0555_RF15","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1212\/WNL.52.6.1191","article-title":"Lamotrigine-induced tourettism","volume":"52","author":"Lombroso","year":"1999","journal-title":"Neurology"},{"key":"10.1053\/seiz.2001.0555_RF16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1157.1986.tb03573.x","article-title":"Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action","volume":"27","author":"Leach","year":"1986","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0555_RF17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1528-1157.1991.tb05879.x","article-title":"Excitatory amino acid transmitters in epilepsy","volume":"32","author":"Meldrum","year":"1991","journal-title":"Epilepsia"},{"key":"10.1053\/seiz.2001.0555_RF18","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.48.5.1282","article-title":"Lamotrigine trail in idiopathic Parkinsonism: a double-blind, placebo-controlled, crossover study","volume":"48","author":"Shinotoh","year":"1997","journal-title":"Neurology"},{"key":"10.1053\/seiz.2001.0555_RF19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0149-7634(96)00039-5","article-title":"Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease","volume":"21","author":"Starr","year":"1997","journal-title":"Neuroscience and Biobehavioural Review"},{"key":"10.1053\/seiz.2001.0555_RF20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00007691-199904000-00006","article-title":"Lamotrigine drug interactions in a TDM material","volume":"21","author":"Bottiger","year":"1999","journal-title":"Therapeutic Drug Monitoring"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131101905552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131101905552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:26:47Z","timestamp":1761010007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131101905552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S1059131101905552"],"URL":"https:\/\/doi.org\/10.1053\/seiz.2001.0555","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticonvulsants-induced chorea: a role for pharmacodynamic drug interaction?","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/seiz.2001.0555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 BEA Trading, Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}